PubRank

Lucie Heinzerling

Author PubWeight™ 14.29‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 T cell costimulation molecules CD80/86 inhibit osteoclast differentiation by inducing the IDO/tryptophan pathway. Sci Transl Med 2014 1.56
2 Recombinant measles virus induces cytolysis of cutaneous T-cell lymphoma in vitro and in vivo. J Invest Dermatol 2006 1.52
3 Clinical research in cutaneous T-cell lymphoma moving forward. Arch Dermatol 2008 1.39
4 Fucosyltransferase VII-deficient mice with defective E-, P-, and L-selectin ligands show impaired CD4+ and CD8+ T cell migration into the skin, but normal extravasation into visceral organs. J Immunol 2002 1.07
5 Autoimmune Colitis and Subsequent CMV-induced Hepatitis After Treatment With Ipilimumab. J Immunother 2015 0.86
6 IP-10-encoding plasmid DNA therapy exhibits anti-tumor and anti-metastatic efficiency. Exp Dermatol 2004 0.85
7 Increased skin and mucosal toxicity in the combination of vemurafenib with radiation therapy. Strahlenther Onkol 2014 0.84
8 Pathogenetic Implications of BRAF Mutation Distribution in Stage IV Melanoma Patients. Dermatology 2015 0.82
9 Immunotherapy of metastatic melanoma by intratumoral injections of Vero cells producing human IL-2: phase II randomized study comparing two dose levels. Cancer Gene Ther 2002 0.81
10 Sensitive allele-specific real-time PCR test for mutations in BRAF codon V600 in skin melanoma. Melanoma Res 2014 0.80
11 Interleukin-2: a potential treatment option for postherpetic neuralgia? Clin Infect Dis 2006 0.78
12 Steroid-sparing effect of pimecrolimus cream 1% in children with severe atopic dermatitis. Dermatology 2007 0.78
13 Anti-cytotoxic T-cell lymphocyte antigen-4-induced regression of spinal cord metastases in association with renal failure, atypical pneumonia, vision loss, and hearing loss. J Clin Oncol 2012 0.77
14 Twelve-year survival and immune correlates in dendritic cell-vaccinated melanoma patients. JCI Insight 2017 0.75
15 Preferences of German melanoma patients for interferon (IFN) α-2b toxicities (the DeCOG "GERMELATOX survey") versus melanoma recurrence to quantify patients' relative values for adjuvant therapy. Medicine (Baltimore) 2016 0.75